Table 1 Comparison of patient’s characteristics between the non-difficult group and the difficult group.

From: Factors associated with difficulty in crossing the culprit lesion of acute myocardial infarction

 

All n = 937

Non-difficult group n = 876

Difficult group n = 61

p-value

Age, years

70.2 ± 12.5

70.0 ± 12.6

73.8 ± 9.7

0.027

Male, n (%)

711 (75.9)

669 (76.4)

42 (68.9)

0.185

Physical examination

Height (cm)

161.7 ± 10.2 (n = 934)

161.9 ± 10.2 (n = 873)

158.9 ± 9.9

0.021

Body weight (kg)

63.1 ± 13.6 (n = 934)

63.3 ± 13.6 (n = 873)

60.5 ± 13.2

0.080

Systolic blood pressure at admission (mmHg)

140.3 ± 32.8 (n = 932)

140.0 ± 32.6 (n = 871)

144.7 ± 35.3

0.283

Diastolic blood pressure at admission (mmHg)

80.5 ± 20.5 (n = 931)

80.4 ± 20.3 (n = 870)

82.0 ± 22.6

0.566

Heart rate at admission (beat per minute)

82.0 ± 22.3 (n = 933)

81.4 ± 21.5 (n = 872)

89.3 ± 31.0

0.123

Underlying disease

Hypertension, n (%)

762/936 (81.4)

708/875 (80.9)

54 (88.5)

0.140

Diabetes mellitus, n (%)

417/931 (44.8)

384/871 (44.1)

33/60 (55.0)

0.100

Dyslipidemia, n (%)

583/932 (62.6)

539/871 (61.9)

44 (72.1)

0.110

Hemodialysis, n (%)

89 (9.5)

79 (9.0)

10 (16.4)

0.057

History of previous PCI, n (%)

209 (22.3)

187 (21.3)

22 (36.1)

0.008

History of previous CABG, n (%)

38 (4.1)

34 (3.9)

4 (6.6)

0.306

History of previous MI, n (%)

148 (15.8)

140 (16.0)

8 (13.1)

0.553

Current smoker, n (%)

291/920 (31.6)

277/860 (32.2)

14/60 (23.3)

0.153

Medication before admission

Aspirin, n (%)

304/930 (32.7)

273/870 (31.4)

31/60 (51.7)

0.001

Thienopyridine, n (%)

181/930 (19.5)

161//870 (18.5)

20/60 (33.3)

0.005

Beta-blocker, n (%)

222/911 (24.4)

203/852 (23.8)

19/59 (32.2)

0.147

ACE-inhibitor, ARB, n (%)

370/912 (40.6)

344/853 (40.3)

26/59 (44.1)

0.572

Calcium channel blocker, n (%)

347/910 (38.1)

325/851 (38.2)

22/59 (37.3)

0.890

Statin, n (%)

327/917 (35.7)

299/858 (34.8)

28/59 (47.5)

0.050

Diuretic, n (%)

124/915 (13.6)

112/856 (13.1)

12/59 (20.3)

0.115

Hypoglycemic agents, n (%)

242/920 (26.3)

217/861 (25.2)

25/59 (42.4)

0.004

Insulin, n (%)

63/922 (6.8)

57/863 (6.6)

6/59 (10.2)

0.294

Laboratory data at admission

Serum creatinine (mg/dl)

1.66 ± 2.31

1.61 ± 2.24

2.30 ± 3.16

0.419

Estimated GFR (ml/min/1.73m2)

60.9 ± 31.8

61.0 ± 29.6

60.3 ± 54.7

0.242

Hemoglobin (g/dl)

13.2 ± 2.14

13.2 ± 2.09

12.5 ± 2.61

0.016

BNP (pg/ml)

420.3 ± 686.3 (n = 891)

394.4 ± 656.1 (n = 831)

778.3 ± 953.5 (n = 60)

 < 0.001

Killip class

0.003

1 or 2

736 (78.5)

697 (79.6)

39 (63.9)

3

99 (10.6)

85 (9.7)

14 (23.0)

4

102 (10.9)

94 (10.7)

8 (13.1)

Cardiac arrest at prehospital or ER, n (%)

55 (5.9)

48 (5.5)

7 (11.5)

0.054

Shock vital at prehospital or ER, n (%)

117 (12.5)

109 (12.4)

8 (13.1)

0.878

Admission within 24 h of onset

796/932 (85.4)

751/871 (86.2)

45 (73.8)

0.008

STEMI (vs NSTEMI)

563 (60.1)

533 (60.8)

30 (49.2)

0.072

Culprit lesion

0.456

Left main – left anterior descending artery, n (%)

477 (50.9)

443 (50.6)

34 (55.7)

Right coronary artery, n (%)

311 (33.2)

296 (33.8)

15 (24.6)

Left circumflex, n (%)

141 (15.0)

130 (14.8)

11 (18.0)

Graft, n (%)

8 (0.9)

7 (0.8)

1 (1.6)

Number of narrowed coronary arteries

0.031

1 vessel disease, n (%)

403 (43.0)

382 (43.6)

21 (34.4)

2 vessel disease, n (%)

311 (33.2)

294 (33.6)

17 (27.9)

3 vessel disease, n (%)

223 (23.8)

200 (22.8)

23 (37.7)

Left main trunk lesion, n (%)

101 (10.8)

95 (10.8)

6 (9.8)

0.806

Left main trunk bifurcation lesion, n (%)

53 (5.7)

50 (5.7)

3 (4.9)

0.796

Ostia lesion, n (%)

77 (8.2)

69 (7.9)

8 (13.1)

0.150

Bifurcation lesion, n (%)

217 (23.2)

207 (23.6)

10 (16.4)

0.195

Initial TIMI flow grade of culprit

0.003

0

350 (37.4)

319 (36.4)

31 (50.8)

1

88 (9.4)

79 (9.0)

9 (14.8)

2

160 (17.1)

148 (16.9)

12 (19.7)

3

339 (36.2)

330 (37.7)

9 (14.8)

TIMI Thrombus grade

0.002

0

0

0

0

1

479 (51.1)

458 (52.3)

21 (34.4)

2

34 (3.6)

34 (3.9)

0

3

50 (5.3)

49 (5.6)

1 (1.6)

4

20 (2.1)

18 (2.1)

2 (3.3)

5

354 (37.8)

317 (36.2)

37 (60.7)

Lesion length (mm)

16.1 ± 10.2

16.0 ± 10.1

18.0 ± 11.7

0.279

Reference diameter (mm)

2.57 ± 0.75

2.59 ± 0.75

2.18 ± 0.65

 < 0.001

Proximal reference diameter (mm)

2.72 ± 0.66

2.79 ± 0.65

2.43 ± 0.65

 < 0.001

Tortuosity

0.481

Mild tortuosity, n (%)

815 (87.0)

765 (87.3)

50 (82.0)

Moderate tortuosity, n (%)

87 (9.3)

79 (9.0)

8 (13.1)

Excessive tortuosity, n (%)

35 (3.7)

32 (3.7)

3 (4.9)

Eccentricity

0.088

Concentric, n (%)

871 (93.0)

811 (92.6)

60 (98.4)

Eccentric, n (%)

66 (7.0)

65 (7.4)

1 (1.6)

Calcification

 < 0.001

None-mild, n (%)

709 (75.7)

680 (77.6)

29 (47.5)

Moderate, n (%)

132 (14.1)

113 (12.9)

19 (31.1)

Severe, n (%)

96 (10.2)

83 (9.5)

13 (21.3)

Type of obstruction site

 < 0.001

Blunt

171 (18.2)

131 (15.0)

40 (65.6)

Tapered

766 (81.7)

745 (85.0)

21 (34.4)

In-stent lesion

80 (8.5)

69 (7.9)

11 (18.0)

0.006

The presence of collateral to the culprit lesion (Rentrop grade)

0.001

0

701 (74.8)

668 (76.3)

33 (54.1)

1

165 (17.6)

148 (16.9)

17 (27.9)

2

66 (7.0)

56 (6.4)

10 (16.4)

3

5 (0.5)

4 (0.5)

1 (1.6)

Occurrence of slow flow in PCI, n (%)

63 (6.7)

61 (7.0)

2 (3.3)

0.267

Approach site

0.070

Trans-radial coronary intervention, n (%)

565 (60.3)

536 (61.2)

29 (47.5)

Trans-brachial coronary intervention, n (%)

32 (3.4)

28 (3.2)

4 (6.6)

Trans-femoral coronary intervention, n (%)

340 (36.3)

312 (35.6)

28 (45.9)

PCI procedure

0.009

Plain old balloon angioplasty, n (%)

54 (5.8)

46 (5.3)

8 (13.1)

Aspiration only, n (%)

6 (0.6)

6 (0.7)

0

Drug coating balloon angioplasty, n (%)

42 (4.5)

37 (4.2)

5 (8.2)

Bare metal stent, n (%)

23 (2.5)

22 (2.5)

1 (1.6)

Drug eluting stent, n (%)

803 (85.7)

758 (86.5)

45 (73.8)

POBA and aspiration, n (%)

6 (0.6)

4 (0.5)

2 (3.3)

Other, n (%)

3 (0.3)

3 (0.3)

0

Size of guiding catheter (Fr)

 < 0.001

6

584 (62.4)

563 (64.3)

21 (34.4)

7

343 (36.6)

307 (35.0)

36 (59.0)

8

10 (1.1)

6 (0.7)

4 (6.6)

Number of guiding catheters

 < 0.001

1

868 (92.6)

822 (93.8)

46 (75.4)

2

61 (6.5)

49 (5.6)

12 (19.7)

 ≥ 3

8 (0.9)

5 (0.6)

3 (4.9)

Number of guide wires

 < 0.001

1

506 (54.0)

506 (57.8)

0

2

315 (33.6)

287 (32.8)

28 (45.9)

 ≥ 3

116 (12.4)

83 (9.5)

33 (54.1)

Number of stents

0.002

0

121 (12.9)

105 (12.0)

16 (26.2)

1

710 (75.8)

676 (77.2)

34 (55.7)

2

98 (10.5)

88 (10.0)

10 (16.4)

 ≥ 3

8 (0.9)

7 (0.8)

1 (1.6)

Number of balloons

 < 0.001

0

29 (3.1)

29 (3.3)

0

1

409 (43.6)

392 (44.7)

17 (27.9)

2

350 (37.4)

328 (37.4)

22 (36.1)

 ≥ 3

149 (15.9)

127 (14.5)

22 (36.1)

Use of guide-extension-catheter, n (%)

94 (10.0)

81 (9.2)

13 (21.3)

0.002

Use of microcatheter, n (%)

279 (29.8)

222 (25.3)

57 (93.4)

 < 0.001

Use of aspiration catheter, n (%)

152 (16.2)

146 (16.7)

6 (9.8)

0.162

Use of rotational coronary atherectomy, n (%)

42 (4.5)

37 (4.2)

5 (8.2)

0.147

IVUS guide, n (%)

907 (96.8)

848 (96.8)

59 (96.7)

0.972

OCT/OFDI guide, n (%)

19 (2.0)

19 (2.2)

0

0.245

Temporary pacemaker, n (%)

67 (7.2)

63 (7.2)

4 (6.6)

0.852

Intra-aortic balloon pumping support, n (%)

97 (10.4)

90 (10.3)

7 (11.5)

0.766

V-A ECMO, n (%)

28 (3.0)

26 (3.0)

2 (3.3)

0.890

Amount of contrast media (ml)

126.6 ± 48.7

125.5 ± 47.8

142.8 ± 58.1

0.010

Fluoroscopy time (minutes)

24.7 ± 14.1

23.4 ± 12.5

43.0 ± 21.9

 < 0.001

  1. Data are expressed as the mean ± SD or number (percentage). A Student’s t test was used for normally distributed continuous variables, a Mann–Whitney U test was used for abnormally distributed continuous variables, and a chi-square test was used for categorical variables.
  2. PCI indicates percutaneous coronary intervention, CABG coronary artery bypass grafting, MI myocardial infarction, ACE Angiotensin converting enzyme, ARB Angiotensin II receptor blocker, GFR glemerular filtration rate, BNP brain natriuretic peptide, ER emergency room, TIMI Thrombolysis in myocardial infarction, IVUS intravascular ultrasound, OCT/OFDI optical coherence tomography/optical frequency domain imaging, V-A ECMO veno-arterial extra-corporeal membranous oxygenation.